Receiving of frozen Comirnaty concentrate for adults and adolescents in ultra-low temperature freezers in Trusts

Ian Allen, Pharmacy Quality Assurance Regional Specialist (NW), North West Pharmaceutical Quality AssurancePublished Last updated See all updates

Instructions for receiving frozen Comirnaty concentrate for adults and adolescents are provided.

Purpose

The attached standard operating procedure outlines how Comirnaty concentrate for adults and adolescents vaccines should be unpacked and stored.

Presentation

The attachment is presented in Word to enable adaptation locally, or as reference source to check that existing local procedures are robust and comprehensive.
Within the SOP:

  • GREEN TEXT indicates that detail is awaited, and will be added when available;
  • RED TEXT indicates where detail is to be added locally.

Attachments

Other handling content for Trusts

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional who needs further advice, get in touch with us. We answer questions about Medicines Optimisation issues, including those about the COVID-19 vaccination programme. Help us to help you: tell us where on our site you were.

Change history

  1. Reference to Comirnaty (10 microgram/dose) concentrate for Children 5-11 years removed as this presentation no longer to be delivered frozen
  1. Changed throughout to include Children 5-11 years product. Removal of reference to Regulation 174 product.
  1. Content reviewed and accurate
  1. Updated to reflect availability of Comirnaty-branded product and associated changes
  1. Published